Olon Group, a global pharmaceutical CDMO, appointed Jérôme Bédier as CEO of its French entities and Andrea Conforto as M&S VP ...

QRS Holdings has chosen to grow its Newark, Delaware, headquarters with a $16.6 million laboratory and office expansion.

Merck KGaA, Darmstadt, Germany, a science and technology company, has entered into a definitive agreement to acquire ...

Thermo Fisher Scientific is employing an enhanced platform technology and a new CHO K-1 cell line that can reduce timelines ...

Precision AQ, a life sciences company, has appointed Dan Cummings as its first Chief Commercial Officer (CCO).

Prilenia Therapeutics has entered into a collaboration & license agreement with Ferrer for the commercialization and further development of pridopidine in Europe and other select markets.

Biohaven will receive up to $600 million to support ongoing clinical trials and the full development of its portfolio.

Single Use Support, a provider of advanced fluid management and cold chain solutions for the biopharmaceutical industry, has ...

The FDA has approved Akeso Inc.’s penpulimab-kcqx in combination with cisplatin or carboplatin and gemcitabine for the first-line treatment of adult recurrent or metastatic NPC.

CPTx GmbH, a pioneer in the therapeutic development and manufacturing of novel medicines built with single-stranded DNA, has ...

Evotec SE has announced substantial progress in its strategic research collaboration with Bristol Myers Squibb.